Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux Disease
- 1 November 2005
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 50 (11) , 2009-2018
- https://doi.org/10.1007/s10620-005-3000-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Duodenal fat intensifies the perception of heartburnGut, 2001
- Pathophysiology and Pharmacological Treatment of Gastroesophageal Reflux DiseaseDigestive Diseases, 2000
- Functional esophageal disordersGut, 1999
- A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjectsAlimentary Pharmacology & Therapeutics, 1998
- Gastro-oesophageal reflux disease in primary careEuropean Journal of Gastroenterology & Hepatology, 1998
- Endoscopy‐negative acid reflux diseaseAlimentary Pharmacology & Therapeutics, 1997
- Current practice and future perspectives in the management of gastro-oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1997
- Heartburn without Oesophagitis: Efficacy of Omeprazole Therapy and Features Determining Therapeutic ResponseScandinavian Journal of Gastroenterology, 1997
- Pathogenesis and treatment of acid peptic disorders: comparison of proton pump inhibitors with other antiulcer agentsClinical Therapeutics, 1996
- Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.Gut, 1995